NCT06153927

Brief Summary

The current study evaluated the diagnostic performance for myocardial ischemia of on-site automatic CCTA-derived FFR (CT-FFR) using a commercially available workstation as compared with invasive FFR as a reference. The diagnostic performance of CT-FFR was compared to that of CCTA diameter stenosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
332

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

November 22, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 1, 2023

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

1.2 years

First QC Date

November 22, 2023

Last Update Submit

November 22, 2023

Conditions

Keywords

Computed Tomography-based Fractional Flow ReserveCoronary Computed Tomography AngiographyFractional Flow ReserveCoronary Artery Disease

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of CT-FFR

    Diagnostic accuracy of CT-FFR to detect hemodynamically significant CAD evaluated with an invasive FFR

    At the time of test

Secondary Outcomes (4)

  • Spearman's correlation coefficient of CT-FFR with FFR

    At the time of test

  • Agreement between CT-FFR and FFR

    At the time of test

  • Comparison of diagnostic performance of CT-FFR to that of CCTA stenosis

    At the time of test

  • Comparison of discriminant ability of CT-FFR to that of CCTA stenosis

    At the time of test

Study Arms (1)

Patients with CCTA and FFR assessment

Patients with CAD who underwent CCTA, invasive coronary angiography, and FFR measurement will be included in this study.

Diagnostic Test: CT-FFR

Interventions

CT-FFRDIAGNOSTIC_TEST

CT-FFR was calculated using HeartMedi+ 1.0 according to the manufacturer's instructions

Patients with CCTA and FFR assessment

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

CAD patients who underwent CCTA, invasive coronary angiography, and FFR measurement will be included in this study.

You may qualify if:

  • adults aged 20 years or older
  • individuals who had undergone ≥ 64 multidetector row CCTA within 90 days before invasive coronary angiography and FFR measurement
  • individuals who had not experienced any clinical events or significant clinical changes between the time of CCTA and invasive coronary angiography

You may not qualify if:

  • previous coronary intervention or coronary bypass surgery in the target vessel
  • invasive coronary angiography under unstable conditions
  • previous myocardial infarction at target vessel territory
  • congenital heart disease
  • moderate or severe valvular heart disease
  • previous valvular heart surgery
  • left ventricular ejection fraction ≤40% or left ventricular hypertrophy
  • previous cardiac device implantation
  • body mass index \>35 kg/m2
  • poor FFR tracing quality
  • no information on the position of the FFR pressure wire
  • heart rate ≥100 beats/min during CCTA
  • CCTA calcium score ≥1000
  • no nitroglycerin prior to CCTA
  • CCTA slice thickness \>1.0 mm
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Bon-Kwon Koo, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 22, 2023

First Posted

December 1, 2023

Study Start

May 26, 2022

Primary Completion

July 30, 2023

Study Completion

October 31, 2023

Last Updated

December 1, 2023

Record last verified: 2023-11

Locations